Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

PCOS is linked to low-grade chronic inflammation.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Certain gene variations increase the risk of alopecia areata in Koreans.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Chicken feather gene mutation helps understand human hair disorders.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Tertiary lymphoid structures are important in immunotherapy and need more research.

Stopping Cyclosporine A led to hair regrowth in a child with alopecia.